Highlights Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
18.55 ^USD	+3.75%		+8.51%	+5.76%

Apr. 23	Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	MT
Apr. 23	Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises	Apr. 23	MT
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Posts Q1 Revenue $79.9M, vs. Street Est of $78.5M	Apr. 23	MT
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	Apr. 02	CI
Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase	Feb. 28	MT
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q4 Revenue $83.4M, vs. Street Est of $72.3M	Feb. 28	MT
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for the Year 2024	Jan. 08	CI
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q3 Revenue $67M, vs. Street Est of $64.4M	23-10-31	MT
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for 2023	23-10-31	CI
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-31	CI
Kiniksa Pharmaceuticals' Shares Rise as Q2 Net Income, Revenue Advance	23-07-25	MT
- (KNSA) KINIKSA PHARMACEUTICALS Q2 EPS $0.21	23-07-25	MT
Kiniksa Pharmaceuticals Q2 Net Income, Revenue Gain	23-07-25	MT
(KNSA) KINIKSA PHARMACEUTICALS Sees Q3 EPS $0.21	23-07-25	MT
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Reports Q2 Revenue $71.5M, vs. Street Est of $52.2M	23-07-25	MT
Kiniksa Pharmaceuticals, Ltd. Provides Revenue Guidance for 2023	23-07-25	CI
Kiniksa Pharmaceuticals, Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
Kiniksa Pharmaceuticals Jumps After Q1 Results Beat Estimates	23-05-02	MT
Kiniksa Pharmaceuticals, Ltd. Increases Sales Guidance for 2023	23-05-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kiniksa Pharmaceuticals, Ltd.

Equities

KNSA

BMG5269C1010

Highlights

Filters